Alkermes/Genentech
Executive Summary
NDA for Nutropin Depot sustained release human growth hormone will be filed in the first quarter of 1999, Alkermes CEO Richard Pops said Jan. 13. A December 1998 pre-NDA meeting with FDA was "very successful," Pops reported, with the agency indicating that there would be no impediment to filing. Nutropin Depot will be manufactured at Alkermes' Cambridge, Mass. facility, Pops said